Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2016
Total Assets: $180.4M
Liabilities Breakdown FY2016
Total Liabilities: $18.1M
Asset Breakdown
Total Assets: $180.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $49.7M | 27.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.8M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $127.9M | 70.9% |
Liabilities Breakdown
Total Liabilities: $18.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.8M | 26.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.4M | 73.8% |